文献速递肿瘤 PET/CT骨显像与常规 SPECT

乳腺专用伽马成像与正电子成像的临床价值:进展综述

The Clinical Value of Breast Specific Gamma Imaging and Positron Imaging: An Update.
PubMed 文献 · Semin Nucl Med · 2022-03-25

本文综述乳腺专用伽马成像与正电子成像在乳腺癌管理中的临床价值与前景。前者使用99mTc-甲氧基异丁基异腈,后者使用18F-氟脱氧葡萄糖,主要用于检出直径小于1 cm的小病灶(尤其致密乳腺患者)、评估术前新辅助治疗疗效、规划手术方式及检测复发。

要点

  • 乳腺专用伽马成像用99mTc-甲氧基异丁基异腈,正电子成像用18F-氟脱氧葡萄糖。
  • 两类系统主要用于检出直径小于1 cm的病灶,尤其适用于致密乳腺患者。
  • 亦用于评估术前新辅助治疗疗效、规划保乳与全乳切除及检测复发。

核心结论

  • 将更高灵敏度与空间分辨率的扫描仪与新型放射性药物结合,可越来越多地在个体患者中获得乳腺癌分子层面病理信息。

研究设计与样本

  • 本文为综述,回顾乳腺专用伽马成像与正电子成像领域的临床影响与未来前景。

主要发现

  • 乳腺专用伽马成像系统采用单头或双头闪烁探测器或半导体探测器并配乳腺实质轻压迫装置,放射性药物为99mTc-甲氧基异丁基异腈。
  • 正电子成像系统采用对置面板探测器和环形探测器,放射性药物为18F-氟脱氧葡萄糖。
  • 两类系统主要用于检出直径小于1 cm的小病灶,尤其用于致密乳腺患者。
  • 两类系统还用于评估术前新辅助治疗疗效、规划手术方式(保乳手术与全乳切除)及检测复发。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the management of patients with breast cancer (BC), a mammography contributed to screen an early-stage patient, to plan a therapy strategy, to evaluate a therapy outcome, to detect a recurrence, and to reduce a mortality. Currently, various imaging modalities, such as CT, MR, Ultrasound (US), SPECT/CT, PET/CT, PET/MR have been utilized for the management of BC patients. In order to overcome a limited spatial resolution and sensitivity of whole-body systems in nuclear medicine imaging, dedicated breast imaging modalities were developed. One is a gamma imaging system with single/dual head scintillation detectors or semiconductor detectors associated with light compression device for breast parenchyma. Radiopharmaceutical for the gamma imaging is 99mTc-sestamibi. Another is a positron imaging system with opposite-type panel detectors and ring-shaped type detectors. Radiopharmaceutical for positron imaging is 18F-fluorodeoxyglucose. The breast-specific gamma and positron imaging systems were utilized mainly to detect small lesions less than 1 cm in diameter especially in patients with dense breast, to evaluate an effect of preoperative neo-adjuvant therapy, to plan surgical procedures (conservative-surgery vs mastectomy), and to detect a recurrence. By combining higher sensitivity and spatial resolution scanners with new radiopharmaceuticals, an information on molecular-level pathology of BC is increasingly available in an individual patient. This article reviewed clinical impact and future perspective of this field.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Hatazawa J. The Clinical Value of Breast Specific Gamma Imaging and Positron Imaging: An Update. Semin Nucl Med. 2022. PMID: 35346487. doi:10.1053/j.semnuclmed.2022.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。